Know Cancer

or
forgot password

Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy Other Than Surgical Resection Alone for Newly Diagnosed Head and Neck Cancer


N/A
18 Years
N/A
Not Enrolling
Both
Head and Neck Cancer

Thank you

Trial Information

Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy Other Than Surgical Resection Alone for Newly Diagnosed Head and Neck Cancer


Inclusion Criteria:



- Pathologically (histologically or cytologically) confirmed new diagnosis of carcinoma
involving the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or neck node
metastasis from unknown origin

- Scheduled to receive radiotherapy and/or drug therapy including chemotherapy,
biologic therapy and targeted therapy

- Written informed consent

Exclusion Criteria:

- Registry participation does not exclude participation in clinical trials.

- Patients scheduled to receive or who have received surgery are eligible for Registry
participation as long as they are also scheduled to receive medical therapy.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

Patterns of care for head and neck cancer

Outcome Time Frame:

up to 10 years

Safety Issue:

No

Principal Investigator

Mednet Solutions

Investigator Role:

Study Director

Investigator Affiliation:

Mednet Solutions

Authority:

United States: Food and Drug Administration

Study ID:

13440

NCT ID:

NCT01080313

Start Date:

August 2005

Completion Date:

December 2011

Related Keywords:

  • Head and Neck Cancer
  • Head and Neck Neoplasms

Name

Location

Mednet SolutionsMinnetonka, Minnesota  55305